(Q64449144)

English

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

Elisabeth Sanders

4

object named as

Elisabeth A M Sanders

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Lotte H Hendrikx

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Guy A M Berbers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Reinier H Veenhoven

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anne-Marie Buisman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6530-6536

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

The seroepidemiology of Bordetella pertussis infection in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Resurgence of pertussis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Recent developments in pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis sources of infection and routes of transmission in the vaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis in adults: frequency of transmission after household exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inacti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Improving the cellular pertussis vaccine: increased potency and consistency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Human B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Crucial role of antibodies to pertactin in Bordetella pertussis immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.08.052

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64449144&oldid=1402058691"